Celgene Expands Cancer Portfolio

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)

Published: 15 Dec-2009

DOI: 10.3833/pdr.v2009.i12.1286     ISSN: 1756-7874

Section: Mergers & Acquisitions



Celgene Corporation announced a definitive merger agreement to acquire the privately-held biopharmaceutical company, Gloucester Pharmaceuticals, for a total of US$640 M to build its cancer drugs portfolio...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details